Fred E. Bertrand
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 7
- Hedgehog Signaling Pathway Studies 6
- Developmental Biology and Gene Regulation 4
- Wnt/β-catenin signaling in development and cancer 3
- Oncology 9
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- James A. McCubrey (10 shared papers)George Sigounas (7 shared papers)Linda S. Steelman (7 shared papers)Massimo Libra (2 shared papers)Jarrett T. Whelan (3 shared papers)Richard A. Franklin (5 shared papers)Caroline Angus (3 shared papers)Steven L. Abrams (3 shared papers)
- Journals
- Cell Cycle (6 papers)Nuclear Physics A (3 papers)Advances in Biological Regulation (3 papers)The Journal of Immunology (2 papers)European Journal of Immunology (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Fred E. Bertrand
37 papers receiving 2.3k citations
Fred E. Bertrand's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 313
- Oncology 489
- Molecular Biology 1.2k
- Hematology 130
- Pathology and Forensic Medicine 177
Countries citing papers authored by Fred E. Bertrand
This map shows the geographic impact of Fred E. Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred E. Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred E. Bertrand more than expected).
Fields of papers citing papers by Fred E. Bertrand
This network shows the impact of papers produced by Fred E. Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred E. Bertrand. The network helps show where Fred E. Bertrand may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred E. Bertrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Hit paper breakdown → | 2006 | 565 |
| 2 | 2014 | 413 | |
| 3 | 2012 | 148 | |
| 4 | 1981 | 146 | |
| 5 | 2015 | 144 | |
| 6 | 2015 | 129 | |
| 7 | 1999 | 95 | |
| 8 | 2004 | 83 | |
| 9 | 2007 | 73 | |
| 10 | 2006 | 69 | |
| 11 | 2023 | 57 | |
| 12 | 2009 | 51 | |
| 13 | 2011 | 46 | |
| 14 | 2014 | 45 | |
| 15 | 2005 | 42 | |
| 16 | 2005 | 41 | |
| 17 | 1998 | 27 | |
| 18 | 2001 | 26 | |
| 19 | 2006 | 25 | |
| 20 | 2005 | 23 |
About Fred E. Bertrand
Fred E. Bertrand is a scholar working on Molecular Biology, Oncology, Hematology, Biophysics and Immunology, having authored 38 papers that have together received 2.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Hedgehog Signaling Pathway Studies (6 papers), Developmental Biology and Gene Regulation (4 papers), Nuclear physics research studies (3 papers), Cancer Cells and Metastasis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), HER2/EGFR in Cancer Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Cancer Research (313 citations), Oncology (489 citations), Molecular Biology (1.2k citations), Hematology (130 citations) and Pathology and Forensic Medicine (177 citations). Fred E. Bertrand has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include James A. McCubrey, George Sigounas, Linda S. Steelman, Massimo Libra, Jarrett T. Whelan, Richard A. Franklin, Caroline Angus, Steven L. Abrams, Fumin Chang and David M. Terrian. Their work appears in journals such as Cell Cycle, Nuclear Physics A, Advances in Biological Regulation, The Journal of Immunology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.